Genfit S.A. (GNFT:NASDAQ) closed at $4.85 on November 19, 2025, unchanged on the day. The stock trades 1.6% below its 52-week high of $4.93 and 90.2% above its 52-week low of $2.55. Genfit S.A. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since October 23, 2025, GNFT closed higher on 14 days (6%). Its best day was November 28, 2025 (+13.25%) and its worst was November 21, 2025 (-10.63%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
Genfit is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development.
Find more stocks like GNFT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.